Overactive Bladder Combination Therapy Gets FDA Supplemental Indication
May 9th 2018Astellas Pharma's mirabegron (Mybetriq) will serve as a combination therapy with muscarinic antagonist solifenacin succinate (VESIcare) for the treatment of overactive bladder in patients with particular symptoms.
Read More
Disposable Kit Pre-Market Approved for Lumbar Spinal Stenosis Device
May 2nd 2018The coflex Interlaminar Stabilization disposable instrument kit is a serviceable outpatient set of injection molded instruments provided in a pre-sterilized peel pack for the posterior lumbar motion preservation solution.
Read More